Six genes (CNR2, DPP4, GLP1R, SLC5A1, HTR2C, MCHR1) encode the therapeutic targets in development of type 2 diabetes or obesity. Therefore, these genes can be used to develop drugs with more efficacy and minimal side effects. Here, DPP4 is linked to obesity due to melanocortin 4 receptor deficiency.